Explore
Validate
LearnHPA001366
antibody from Atlas Antibodies
Targeting: CDK16
FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001366 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001366, RRID:AB_1079584
- Product name
- Anti-CDK16
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human CDK16, Gene description: cyclin-dependent kinase 16, Alternative Gene Names: FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1, Validated applications: IHC, WB, Uniprot ID: Q00536, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.4 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway.
CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16
Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth
PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines
PCTAIRE1 Phosphorylates p27 and Regulates Mitosis in Cancer Cells
PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma
Wu C, Lidsky P, Xiao Y, Cheng R, Lee I, Nakayama T, Jiang S, He W, Demeter J, Knight M, Turn R, Rojas-Hernandez L, Ye C, Chiem K, Shon J, Martinez-Sobrido L, Bertozzi C, Nolan G, Nayak J, Milla C, Andino R, Jackson P
Cell 2023;186(1):112-130.e20
Cell 2023;186(1):112-130.e20
PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway.
Wei PL, Huang CY, Chang TC, Lin JC, Lee CC, Prince GMSH, Makondi PT, Chui AW, Chang YJ
International journal of molecular sciences 2023 Jun 11;24(12)
International journal of molecular sciences 2023 Jun 11;24(12)
CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1
Li X, Li J, Xu L, Wei W, Cheng A, Zhang L, Zhang M, Wu G, Cai C
Journal of Experimental & Clinical Cancer Research 2022;41(1)
Journal of Experimental & Clinical Cancer Research 2022;41(1)
Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16
Dixon-Clarke S, Shehata S, Krojer T, Sharpe T, von Delft F, Sakamoto K, Bullock A
Biochemical Journal 2017;474(5):699-713
Biochemical Journal 2017;474(5):699-713
Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth
Yanagi T, Tachikawa K, Wilkie-Grantham R, Hishiki A, Nagai K, Toyonaga E, Chivukula P, Matsuzawa S
Molecular Therapy - Nucleic Acids 2016;5
Molecular Therapy - Nucleic Acids 2016;5
PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines
Villunger A, Yanagi T, Shi R, Aza-Blanc P, Reed J, Matsuzawa S
PLOS ONE 2015;10(3):e0119404
PLOS ONE 2015;10(3):e0119404
PCTAIRE1 Phosphorylates p27 and Regulates Mitosis in Cancer Cells
Yanagi T, Krajewska M, Matsuzawa S, Reed J
Cancer Research 2014;74(20):5795-5807
Cancer Research 2014;74(20):5795-5807
PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma
Yanagi T, Reed J, Matsuzawa S
Oncoscience 2014;1(10):624-633
Oncoscience 2014;1(10):624-633
No comments: Submit comment
No validations: Submit validation data